Home › Funds › Two Sigma Investments › CELC
Two Sigma Investments position in CELC
CELCUITY INC · Health Care
Latest position (Q3 2025)62.78K sh
Reported value held$3.10M
Portfolio Weight0.00%
First reportedQ3 2021
Last changeNew
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 19.57K | $352.00K | New |
| Q4 2021 | 15.70K | $207.00K | Reduce |
| Q1 2024 | 44.22K | $955.17K | New |
| Q2 2024 | 69.44K | $1.14M | Add |
| Q3 2024 | 132.81K | $1.98M | Add |
| Q4 2024 | 51.84K | $678.56K | Reduce |
| Q1 2025 | 13.38K | $135.25K | Reduce |
| Q1 2025 | 13.38K | $135.25K | Reduce |
| Q3 2025 | 62.78K | $3.10M | New |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding CELC
- Vanguard Group 2.28M sh · $227.35M · Q4 2025
- Bank of America Corp 1.47M sh · $153.93M · Q2 2026
- Geode Capital Management 1.11M sh · $116.33M · Q2 2026
- Wellington Management Group 906.60K sh · $94.85M · Q2 2026
- Point72 Asset Management 650.92K sh · $68.10M · Q2 2026
- UBS Group AG 520.95K sh · $54.50M · Q2 2026
- Northern Trust Corp 356.92K sh · $37.34M · Q2 2026
- Charles Schwab Investment Management 320.89K sh · $33.57M · Q2 2026
- Marshall Wace 182.16K sh · $19.06M · Q2 2026
- BlackRock Inc 12.97M sh · $14.74M · Q2 2026
- Citadel Advisors 123.30K sh · $12.90M · Q2 2026
- BNY Mellon 116.37K sh · $12.17M · Q2 2026